Global Short Bowel Syndrome Drugs Market Insights and Forecast to 2028

Publisher Name :
Date: 28-Feb-2022
No. of pages: 106
Inquire Before Buying

Short Bowel Syndrome Drugs market is segmented by Type and by Sale Channel. Players, stakeholders, and other participants in the global Short Bowel Syndrome Drugs market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Sale Channel for the period 2017-2028.

Segment by Type

- Oral Short Bowel Syndrome Drugs

- Tablet Short Bowel Syndrome Drugs

Segment by Sale Channel

- Hospital Pharmacies

- Retail Pharmacies

- Online Pharmacies

By Company

- Emmaus Medical

- Merck

- Takeda

- Ardelyx

- Naia Pharmaceuticals

- Nutrinia

- OxThera

- GLyPharma Therapeutic

- Sancilio Pharmaceuticals

- Zealand Pharma

By Region

- North America

- - U.S.

- - Canada

- Europe

- - Germany

- - France

- - U.K.

- - Italy

- - Russia

- Asia-Pacific

- - China

- - Japan

- - South Korea

- - India

- - Australia

- - China Taiwan

- - Indonesia

- - Thailand

- - Malaysia

- Latin America

- - Mexico

- - Brazil

- - Argentina

- Middle East & Africa

- - Turkey

- - Saudi Arabia

- - UAE

Global Short Bowel Syndrome Drugs Market Insights and Forecast to 2028

Table of Contents
1 Study Coverage
1.1 Short Bowel Syndrome Drugs Product Introduction
1.2 Market by Type
1.2.1 Global Short Bowel Syndrome Drugs Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Oral Short Bowel Syndrome Drugs
1.2.3 Tablet Short Bowel Syndrome Drugs
1.3 Market by Sale Channel
1.3.1 Global Short Bowel Syndrome Drugs Market Size Growth Rate by Sale Channel, 2017 VS 2021 VS 2028
1.3.2 Hospital Pharmacies
1.3.3 Retail Pharmacies
1.3.4 Online Pharmacies
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Short Bowel Syndrome Drugs Sales Estimates and Forecasts 2017-2028
2.2 Global Short Bowel Syndrome Drugs Revenue Estimates and Forecasts 2017-2028
2.3 Global Short Bowel Syndrome Drugs Revenue by Region: 2017 VS 2021 VS 2028
2.4 Global Short Bowel Syndrome Drugs Sales by Region
2.4.1 Global Short Bowel Syndrome Drugs Sales by Region (2017-2022)
2.4.2 Global Sales Short Bowel Syndrome Drugs by Region (2023-2028)
2.5 Global Short Bowel Syndrome Drugs Revenue by Region
2.5.1 Global Short Bowel Syndrome Drugs Revenue by Region (2017-2022)
2.5.2 Global Short Bowel Syndrome Drugs Revenue by Region (2023-2028)
2.6 North America
2.7 Europe
2.8 Asia-Pacific
2.9 Latin America
2.10 Middle East & Africa
3 Competition by Manufacturers
3.1 Global Short Bowel Syndrome Drugs Sales by Manufacturers
3.1.1 Global Top Short Bowel Syndrome Drugs Manufacturers by Sales (2017-2022)
3.1.2 Global Short Bowel Syndrome Drugs Sales Market Share by Manufacturers (2017-2022)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Short Bowel Syndrome Drugs in 2021
3.2 Global Short Bowel Syndrome Drugs Revenue by Manufacturers
3.2.1 Global Short Bowel Syndrome Drugs Revenue by Manufacturers (2017-2022)
3.2.2 Global Short Bowel Syndrome Drugs Revenue Market Share by Manufacturers (2017-2022)
3.2.3 Global Top 10 and Top 5 Companies by Short Bowel Syndrome Drugs Revenue in 2021
3.3 Global Short Bowel Syndrome Drugs Sales Price by Manufacturers (2017-2022)
3.4 Analysis of Competitive Landscape
3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Short Bowel Syndrome Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4.3 Global Short Bowel Syndrome Drugs Manufacturers Geographical Distribution
3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Short Bowel Syndrome Drugs Sales by Type
4.1.1 Global Short Bowel Syndrome Drugs Historical Sales by Type (2017-2022)
4.1.2 Global Short Bowel Syndrome Drugs Forecasted Sales by Type (2023-2028)
4.1.3 Global Short Bowel Syndrome Drugs Sales Market Share by Type (2017-2028)
4.2 Global Short Bowel Syndrome Drugs Revenue by Type
4.2.1 Global Short Bowel Syndrome Drugs Historical Revenue by Type (2017-2022)
4.2.2 Global Short Bowel Syndrome Drugs Forecasted Revenue by Type (2023-2028)
4.2.3 Global Short Bowel Syndrome Drugs Revenue Market Share by Type (2017-2028)
4.3 Global Short Bowel Syndrome Drugs Price by Type
4.3.1 Global Short Bowel Syndrome Drugs Price by Type (2017-2022)
4.3.2 Global Short Bowel Syndrome Drugs Price Forecast by Type (2023-2028)
5 Market Size by Sale Channel
5.1 Global Short Bowel Syndrome Drugs Sales by Sale Channel
5.1.1 Global Short Bowel Syndrome Drugs Historical Sales by Sale Channel (2017-2022)
5.1.2 Global Short Bowel Syndrome Drugs Forecasted Sales by Sale Channel (2023-2028)
5.1.3 Global Short Bowel Syndrome Drugs Sales Market Share by Sale Channel (2017-2028)
5.2 Global Short Bowel Syndrome Drugs Revenue by Sale Channel
5.2.1 Global Short Bowel Syndrome Drugs Historical Revenue by Sale Channel (2017-2022)
5.2.2 Global Short Bowel Syndrome Drugs Forecasted Revenue by Sale Channel (2023-2028)
5.2.3 Global Short Bowel Syndrome Drugs Revenue Market Share by Sale Channel (2017-2028)
5.3 Global Short Bowel Syndrome Drugs Price by Sale Channel
5.3.1 Global Short Bowel Syndrome Drugs Price by Sale Channel (2017-2022)
5.3.2 Global Short Bowel Syndrome Drugs Price Forecast by Sale Channel (2023-2028)
6 North America
6.1 North America Short Bowel Syndrome Drugs Market Size by Type
6.1.1 North America Short Bowel Syndrome Drugs Sales by Type (2017-2028)
6.1.2 North America Short Bowel Syndrome Drugs Revenue by Type (2017-2028)
6.2 North America Short Bowel Syndrome Drugs Market Size by Sale Channel
6.2.1 North America Short Bowel Syndrome Drugs Sales by Sale Channel (2017-2028)
6.2.2 North America Short Bowel Syndrome Drugs Revenue by Sale Channel (2017-2028)
6.3 North America Short Bowel Syndrome Drugs Market Size by Country
6.3.1 North America Short Bowel Syndrome Drugs Sales by Country (2017-2028)
6.3.2 North America Short Bowel Syndrome Drugs Revenue by Country (2017-2028)
6.3.3 U.S.
6.3.4 Canada
7 Europe
7.1 Europe Short Bowel Syndrome Drugs Market Size by Type
7.1.1 Europe Short Bowel Syndrome Drugs Sales by Type (2017-2028)
7.1.2 Europe Short Bowel Syndrome Drugs Revenue by Type (2017-2028)
7.2 Europe Short Bowel Syndrome Drugs Market Size by Sale Channel
7.2.1 Europe Short Bowel Syndrome Drugs Sales by Sale Channel (2017-2028)
7.2.2 Europe Short Bowel Syndrome Drugs Revenue by Sale Channel (2017-2028)
7.3 Europe Short Bowel Syndrome Drugs Market Size by Country
7.3.1 Europe Short Bowel Syndrome Drugs Sales by Country (2017-2028)
7.3.2 Europe Short Bowel Syndrome Drugs Revenue by Country (2017-2028)
7.3.3 Germany
7.3.4 France
7.3.5 U.K.
7.3.6 Italy
7.3.7 Russia
8 Asia Pacific
8.1 Asia Pacific Short Bowel Syndrome Drugs Market Size by Type
8.1.1 Asia Pacific Short Bowel Syndrome Drugs Sales by Type (2017-2028)
8.1.2 Asia Pacific Short Bowel Syndrome Drugs Revenue by Type (2017-2028)
8.2 Asia Pacific Short Bowel Syndrome Drugs Market Size by Sale Channel
8.2.1 Asia Pacific Short Bowel Syndrome Drugs Sales by Sale Channel (2017-2028)
8.2.2 Asia Pacific Short Bowel Syndrome Drugs Revenue by Sale Channel (2017-2028)
8.3 Asia Pacific Short Bowel Syndrome Drugs Market Size by Region
8.3.1 Asia Pacific Short Bowel Syndrome Drugs Sales by Region (2017-2028)
8.3.2 Asia Pacific Short Bowel Syndrome Drugs Revenue by Region (2017-2028)
8.3.3 China
8.3.4 Japan
8.3.5 South Korea
8.3.6 India
8.3.7 Australia
8.3.8 China Taiwan
8.3.9 Indonesia
8.3.10 Thailand
8.3.11 Malaysia
9 Latin America
9.1 Latin America Short Bowel Syndrome Drugs Market Size by Type
9.1.1 Latin America Short Bowel Syndrome Drugs Sales by Type (2017-2028)
9.1.2 Latin America Short Bowel Syndrome Drugs Revenue by Type (2017-2028)
9.2 Latin America Short Bowel Syndrome Drugs Market Size by Sale Channel
9.2.1 Latin America Short Bowel Syndrome Drugs Sales by Sale Channel (2017-2028)
9.2.2 Latin America Short Bowel Syndrome Drugs Revenue by Sale Channel (2017-2028)
9.3 Latin America Short Bowel Syndrome Drugs Market Size by Country
9.3.1 Latin America Short Bowel Syndrome Drugs Sales by Country (2017-2028)
9.3.2 Latin America Short Bowel Syndrome Drugs Revenue by Country (2017-2028)
9.3.3 Mexico
9.3.4 Brazil
9.3.5 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Short Bowel Syndrome Drugs Market Size by Type
10.1.1 Middle East and Africa Short Bowel Syndrome Drugs Sales by Type (2017-2028)
10.1.2 Middle East and Africa Short Bowel Syndrome Drugs Revenue by Type (2017-2028)
10.2 Middle East and Africa Short Bowel Syndrome Drugs Market Size by Sale Channel
10.2.1 Middle East and Africa Short Bowel Syndrome Drugs Sales by Sale Channel (2017-2028)
10.2.2 Middle East and Africa Short Bowel Syndrome Drugs Revenue by Sale Channel (2017-2028)
10.3 Middle East and Africa Short Bowel Syndrome Drugs Market Size by Country
10.3.1 Middle East and Africa Short Bowel Syndrome Drugs Sales by Country (2017-2028)
10.3.2 Middle East and Africa Short Bowel Syndrome Drugs Revenue by Country (2017-2028)
10.3.3 Turkey
10.3.4 Saudi Arabia
11 Company Profiles
11.1 Emmaus Medical
11.1.1 Emmaus Medical Corporation Information
11.1.2 Emmaus Medical Overview
11.1.3 Emmaus Medical Short Bowel Syndrome Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.1.4 Emmaus Medical Short Bowel Syndrome Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Emmaus Medical Recent Developments
11.2 Merck
11.2.1 Merck Corporation Information
11.2.2 Merck Overview
11.2.3 Merck Short Bowel Syndrome Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.2.4 Merck Short Bowel Syndrome Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 Merck Recent Developments
11.3 Takeda
11.3.1 Takeda Corporation Information
11.3.2 Takeda Overview
11.3.3 Takeda Short Bowel Syndrome Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.3.4 Takeda Short Bowel Syndrome Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Takeda Recent Developments
11.4 Ardelyx
11.4.1 Ardelyx Corporation Information
11.4.2 Ardelyx Overview
11.4.3 Ardelyx Short Bowel Syndrome Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.4.4 Ardelyx Short Bowel Syndrome Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Ardelyx Recent Developments
11.5 Naia Pharmaceuticals
11.5.1 Naia Pharmaceuticals Corporation Information
11.5.2 Naia Pharmaceuticals Overview
11.5.3 Naia Pharmaceuticals Short Bowel Syndrome Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.5.4 Naia Pharmaceuticals Short Bowel Syndrome Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 Naia Pharmaceuticals Recent Developments
11.6 Nutrinia
11.6.1 Nutrinia Corporation Information
11.6.2 Nutrinia Overview
11.6.3 Nutrinia Short Bowel Syndrome Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.6.4 Nutrinia Short Bowel Syndrome Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 Nutrinia Recent Developments
11.7 OxThera
11.7.1 OxThera Corporation Information
11.7.2 OxThera Overview
11.7.3 OxThera Short Bowel Syndrome Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.7.4 OxThera Short Bowel Syndrome Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 OxThera Recent Developments
11.8 GLyPharma Therapeutic
11.8.1 GLyPharma Therapeutic Corporation Information
11.8.2 GLyPharma Therapeutic Overview
11.8.3 GLyPharma Therapeutic Short Bowel Syndrome Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.8.4 GLyPharma Therapeutic Short Bowel Syndrome Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.8.5 GLyPharma Therapeutic Recent Developments
11.9 Sancilio Pharmaceuticals
11.9.1 Sancilio Pharmaceuticals Corporation Information
11.9.2 Sancilio Pharmaceuticals Overview
11.9.3 Sancilio Pharmaceuticals Short Bowel Syndrome Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.9.4 Sancilio Pharmaceuticals Short Bowel Syndrome Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.9.5 Sancilio Pharmaceuticals Recent Developments
11.10 Zealand Pharma
11.10.1 Zealand Pharma Corporation Information
11.10.2 Zealand Pharma Overview
11.10.3 Zealand Pharma Short Bowel Syndrome Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.10.4 Zealand Pharma Short Bowel Syndrome Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.10.5 Zealand Pharma Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Short Bowel Syndrome Drugs Industry Chain Analysis
12.2 Short Bowel Syndrome Drugs Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Short Bowel Syndrome Drugs Production Mode & Process
12.4 Short Bowel Syndrome Drugs Sales and Marketing
12.4.1 Short Bowel Syndrome Drugs Sales Channels
12.4.2 Short Bowel Syndrome Drugs Distributors
12.5 Short Bowel Syndrome Drugs Customers
13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
13.1 Short Bowel Syndrome Drugs Industry Trends
13.2 Short Bowel Syndrome Drugs Market Drivers
13.3 Short Bowel Syndrome Drugs Market Challenges
13.4 Short Bowel Syndrome Drugs Market Restraints
14 Key Findings in The Global Short Bowel Syndrome Drugs Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer
List of Tables
Table 1. Global Short Bowel Syndrome Drugs Market Size Growth Rate by Type, 2017 VS 2021 VS 2028 (US$ Million)
Table 2. Major Manufacturers of Oral Short Bowel Syndrome Drugs
Table 3. Major Manufacturers of Tablet Short Bowel Syndrome Drugs
Table 4. Global Short Bowel Syndrome Drugs Market Size Growth Rate by Sale Channel, 2017 VS 2021 VS 2028 (US$ Million)
Table 5. Global Short Bowel Syndrome Drugs Revenue by Region: 2017 VS 2021 VS 2028 (US$ Million)
Table 6. Global Short Bowel Syndrome Drugs Sales by Region (2017-2022) & (K Pcs)
Table 7. Global Short Bowel Syndrome Drugs Sales Market Share by Region (2017-2022)
Table 8. Global Short Bowel Syndrome Drugs Sales by Region (2023-2028) & (K Pcs)
Table 9. Global Short Bowel Syndrome Drugs Sales Market Share by Region (2023-2028)
Table 10. Global Short Bowel Syndrome Drugs Revenue by Region (2017-2022) & (US$ Million)
Table 11. Global Short Bowel Syndrome Drugs Revenue Market Share by Region (2017-2022)
Table 12. Global Short Bowel Syndrome Drugs Revenue by Region (2023-2028) & (US$ Million)
Table 13. Global Short Bowel Syndrome Drugs Revenue Market Share by Region (2023-2028)
Table 14. Global Short Bowel Syndrome Drugs Sales by Manufacturers (2017-2022) & (K Pcs)
Table 15. Global Short Bowel Syndrome Drugs Sales Share by Manufacturers (2017-2022)
Table 16. Global Short Bowel Syndrome Drugs Revenue by Manufacturers (2017-2022) & (US$ Million)
Table 17. Global Short Bowel Syndrome Drugs Revenue Share by Manufacturers (2017-2022)
Table 18. Short Bowel Syndrome Drugs Price by Manufacturers (2017-2022) &(USD/Pcs)
Table 19. Global Short Bowel Syndrome Drugs Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 20. Global Short Bowel Syndrome Drugs by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Short Bowel Syndrome Drugs as of 2021)
Table 21. Short Bowel Syndrome Drugs Manufacturing Base Distribution and Headquarters
Table 22. Manufacturers Short Bowel Syndrome Drugs Product Offered
Table 23. Date of Manufacturers Enter into Short Bowel Syndrome Drugs Market
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Short Bowel Syndrome Drugs Sales by Type (2017-2022) & (K Pcs)
Table 26. Global Short Bowel Syndrome Drugs Sales by Type (2023-2028) & (K Pcs)
Table 27. Global Short Bowel Syndrome Drugs Sales Share by Type (2017-2022)
Table 28. Global Short Bowel Syndrome Drugs Sales Share by Type (2023-2028)
Table 29. Global Short Bowel Syndrome Drugs Revenue by Type (2017-2022) & (US$ Million)
Table 30. Global Short Bowel Syndrome Drugs Revenue by Type (2023-2028) & (US$ Million)
Table 31. Global Short Bowel Syndrome Drugs Revenue Share by Type (2017-2022)
Table 32. Global Short Bowel Syndrome Drugs Revenue Share by Type (2023-2028)
Table 33. Short Bowel Syndrome Drugs Price by Type (2017-2022) & (USD/Pcs)
Table 34. Global Short Bowel Syndrome Drugs Price Forecast by Type (2023-2028) & (USD/Pcs)
Table 35. Global Short Bowel Syndrome Drugs Sales by Sale Channel (2017-2022) & (K Pcs)
Table 36. Global Short Bowel Syndrome Drugs Sales by Sale Channel (2023-2028) & (K Pcs)
Table 37. Global Short Bowel Syndrome Drugs Sales Share by Sale Channel (2017-2022)
Table 38. Global Short Bowel Syndrome Drugs Sales Share by Sale Channel (2023-2028)
Table 39. Global Short Bowel Syndrome Drugs Revenue by Sale Channel (2017-2022) & (US$ Million)
Table 40. Global Short Bowel Syndrome Drugs Revenue by Sale Channel (2023-2028) & (US$ Million)
Table 41. Global Short Bowel Syndrome Drugs Revenue Share by Sale Channel (2017-2022)
Table 42. Global Short Bowel Syndrome Drugs Revenue Share by Sale Channel (2023-2028)
Table 43. Short Bowel Syndrome Drugs Price by Sale Channel (2017-2022) & (USD/Pcs)
Table 44. Global Short Bowel Syndrome Drugs Price Forecast by Sale Channel (2023-2028) & (USD/Pcs)
Table 45. North America Short Bowel Syndrome Drugs Sales by Type (2017-2022) & (K Pcs)
Table 46. North America Short Bowel Syndrome Drugs Sales by Type (2023-2028) & (K Pcs)
Table 47. North America Short Bowel Syndrome Drugs Revenue by Type (2017-2022) & (US$ Million)
Table 48. North America Short Bowel Syndrome Drugs Revenue by Type (2023-2028) & (US$ Million)
Table 49. North America Short Bowel Syndrome Drugs Sales by Sale Channel (2017-2022) & (K Pcs)
Table 50. North America Short Bowel Syndrome Drugs Sales by Sale Channel (2023-2028) & (K Pcs)
Table 51. North America Short Bowel Syndrome Drugs Revenue by Sale Channel (2017-2022) & (US$ Million)
Table 52. North America Short Bowel Syndrome Drugs Revenue by Sale Channel (2023-2028) & (US$ Million)
Table 53. North America Short Bowel Syndrome Drugs Sales by Country (2017-2022) & (K Pcs)
Table 54. North America Short Bowel Syndrome Drugs Sales by Country (2023-2028) & (K Pcs)
Table 55. North America Short Bowel Syndrome Drugs Revenue by Country (2017-2022) & (US$ Million)
Table 56. North America Short Bowel Syndrome Drugs Revenue by Country (2023-2028) & (US$ Million)
Table 57. Europe Short Bowel Syndrome Drugs Sales by Type (2017-2022) & (K Pcs)
Table 58. Europe Short Bowel Syndrome Drugs Sales by Type (2023-2028) & (K Pcs)
Table 59. Europe Short Bowel Syndrome Drugs Revenue by Type (2017-2022) & (US$ Million)
Table 60. Europe Short Bowel Syndrome Drugs Revenue by Type (2023-2028) & (US$ Million)
Table 61. Europe Short Bowel Syndrome Drugs Sales by Sale Channel (2017-2022) & (K Pcs)
Table 62. Europe Short Bowel Syndrome Drugs Sales by Sale Channel (2023-2028) & (K Pcs)
Table 63. Europe Short Bowel Syndrome Drugs Revenue by Sale Channel (2017-2022) & (US$ Million)
Table 64. Europe Short Bowel Syndrome Drugs Revenue by Sale Channel (2023-2028) & (US$ Million)
Table 65. Europe Short Bowel Syndrome Drugs Sales by Country (2017-2022) & (K Pcs)
Table 66. Europe Short Bowel Syndrome Drugs Sales by Country (2023-2028) & (K Pcs)
Table 67. Europe Short Bowel Syndrome Drugs Revenue by Country (2017-2022) & (US$ Million)
Table 68. Europe Short Bowel Syndrome Drugs Revenue by Country (2023-2028) & (US$ Million)
Table 69. Asia Pacific Short Bowel Syndrome Drugs Sales by Type (2017-2022) & (K Pcs)
Table 70. Asia Pacific Short Bowel Syndrome Drugs Sales by Type (2023-2028) & (K Pcs)
Table 71. Asia Pacific Short Bowel Syndrome Drugs Revenue by Type (2017-2022) & (US$ Million)
Table 72. Asia Pacific Short Bowel Syndrome Drugs Revenue by Type (2023-2028) & (US$ Million)
Table 73. Asia Pacific Short Bowel Syndrome Drugs Sales by Sale Channel (2017-2022) & (K Pcs)
Table 74. Asia Pacific Short Bowel Syndrome Drugs Sales by Sale Channel (2023-2028) & (K Pcs)
Table 75. Asia Pacific Short Bowel Syndrome Drugs Revenue by Sale Channel (2017-2022) & (US$ Million)
Table 76. Asia Pacific Short Bowel Syndrome Drugs Revenue by Sale Channel (2023-2028) & (US$ Million)
Table 77. Asia Pacific Short Bowel Syndrome Drugs Sales by Region (2017-2022) & (K Pcs)
Table 78. Asia Pacific Short Bowel Syndrome Drugs Sales by Region (2023-2028) & (K Pcs)
Table 79. Asia Pacific Short Bowel Syndrome Drugs Revenue by Region (2017-2022) & (US$ Million)
Table 80. Asia Pacific Short Bowel Syndrome Drugs Revenue by Region (2023-2028) & (US$ Million)
Table 81. Latin America Short Bowel Syndrome Drugs Sales by Type (2017-2022) & (K Pcs)
Table 82. Latin America Short Bowel Syndrome Drugs Sales by Type (2023-2028) & (K Pcs)
Table 83. Latin America Short Bowel Syndrome Drugs Revenue by Type (2017-2022) & (US$ Million)
Table 84. Latin America Short Bowel Syndrome Drugs Revenue by Type (2023-2028) & (US$ Million)
Table 85. Latin America Short Bowel Syndrome Drugs Sales by Sale Channel (2017-2022) & (K Pcs)
Table 86. Latin America Short Bowel Syndrome Drugs Sales by Sale Channel (2023-2028) & (K Pcs)
Table 87. Latin America Short Bowel Syndrome Drugs Revenue by Sale Channel (2017-2022) & (US$ Million)
Table 88. Latin America Short Bowel Syndrome Drugs Revenue by Sale Channel (2023-2028) & (US$ Million)
Table 89. Latin America Short Bowel Syndrome Drugs Sales by Country (2017-2022) & (K Pcs)
Table 90. Latin America Short Bowel Syndrome Drugs Sales by Country (2023-2028) & (K Pcs)
Table 91. Latin America Short Bowel Syndrome Drugs Revenue by Country (2017-2022) & (US$ Million)
Table 92. Latin America Short Bowel Syndrome Drugs Revenue by Country (2023-2028) & (US$ Million)
Table 93. Middle East and Africa Short Bowel Syndrome Drugs Sales by Type (2017-2022) & (K Pcs)
Table 94. Middle East and Africa Short Bowel Syndrome Drugs Sales by Type (2023-2028) & (K Pcs)
Table 95. Middle East and Africa Short Bowel Syndrome Drugs Revenue by Type (2017-2022) & (US$ Million)
Table 96. Middle East and Africa Short Bowel Syndrome Drugs Revenue by Type (2023-2028) & (US$ Million)
Table 97. Middle East and Africa Short Bowel Syndrome Drugs Sales by Sale Channel (2017-2022) & (K Pcs)
Table 98. Middle East and Africa Short Bowel Syndrome Drugs Sales by Sale Channel (2023-2028) & (K Pcs)
Table 99. Middle East and Africa Short Bowel Syndrome Drugs Revenue by Sale Channel (2017-2022) & (US$ Million)
Table 100. Middle East and Africa Short Bowel Syndrome Drugs Revenue by Sale Channel (2023-2028) & (US$ Million)
Table 101. Middle East and Africa Short Bowel Syndrome Drugs Sales by Country (2017-2022) & (K Pcs)
Table 102. Middle East and Africa Short Bowel Syndrome Drugs Sales by Country (2023-2028) & (K Pcs)
Table 103. Middle East and Africa Short Bowel Syndrome Drugs Revenue by Country (2017-2022) & (US$ Million)
Table 104. Middle East and Africa Short Bowel Syndrome Drugs Revenue by Country (2023-2028) & (US$ Million)
Table 105. Emmaus Medical Corporation Information
Table 106. Emmaus Medical Description and Major Businesses
Table 107. Emmaus Medical Short Bowel Syndrome Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
Table 108. Emmaus Medical Short Bowel Syndrome Drugs Product Model Numbers, Pictures, Descriptions and Specifications
Table 109. Emmaus Medical Recent Developments
Table 110. Merck Corporation Information
Table 111. Merck Description and Major Businesses
Table 112. Merck Short Bowel Syndrome Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
Table 113. Merck Short Bowel Syndrome Drugs Product Model Numbers, Pictures, Descriptions and Specifications
Table 114. Merck Recent Developments
Table 115. Takeda Corporation Information
Table 116. Takeda Description and Major Businesses
Table 117. Takeda Short Bowel Syndrome Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
Table 118. Takeda Short Bowel Syndrome Drugs Product Model Numbers, Pictures, Descriptions and Specifications
Table 119. Takeda Recent Developments
Table 120. Ardelyx Corporation Information
Table 121. Ardelyx Description and Major Businesses
Table 122. Ardelyx Short Bowel Syndrome Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
Table 123. Ardelyx Short Bowel Syndrome Drugs Product Model Numbers, Pictures, Descriptions and Specifications
Table 124. Ardelyx Recent Developments
Table 125. Naia Pharmaceuticals Corporation Information
Table 126. Naia Pharmaceuticals Description and Major Businesses
Table 127. Naia Pharmaceuticals Short Bowel Syndrome Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
Table 128. Naia Pharmaceuticals Short Bowel Syndrome Drugs Product Model Numbers, Pictures, Descriptions and Specifications
Table 129. Naia Pharmaceuticals Recent Developments
Table 130. Nutrinia Corporation Information
Table 131. Nutrinia Description and Major Businesses
Table 132. Nutrinia Short Bowel Syndrome Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
Table 133. Nutrinia Short Bowel Syndrome Drugs Product Model Numbers, Pictures, Descriptions and Specifications
Table 134. Nutrinia Recent Developments
Table 135. OxThera Corporation Information
Table 136. OxThera Description and Major Businesses
Table 137. OxThera Short Bowel Syndrome Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
Table 138. OxThera Short Bowel Syndrome Drugs Product Model Numbers, Pictures, Descriptions and Specifications
Table 139. OxThera Recent Developments
Table 140. GLyPharma Therapeutic Corporation Information
Table 141. GLyPharma Therapeutic Description and Major Businesses
Table 142. GLyPharma Therapeutic Short Bowel Syndrome Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
Table 143. GLyPharma Therapeutic Short Bowel Syndrome Drugs Product Model Numbers, Pictures, Descriptions and Specifications
Table 144. GLyPharma Therapeutic Recent Developments
Table 145. Sancilio Pharmaceuticals Corporation Information
Table 146. Sancilio Pharmaceuticals Description and Major Businesses
Table 147. Sancilio Pharmaceuticals Short Bowel Syndrome Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
Table 148. Sancilio Pharmaceuticals Short Bowel Syndrome Drugs Product Model Numbers, Pictures, Descriptions and Specifications
Table 149. Sancilio Pharmaceuticals Recent Developments
Table 150. Zealand Pharma Corporation Information
Table 151. Zealand Pharma Description and Major Businesses
Table 152. Zealand Pharma Short Bowel Syndrome Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
Table 153. Zealand Pharma Short Bowel Syndrome Drugs Product Model Numbers, Pictures, Descriptions and Specifications
Table 154. Zealand Pharma Recent Developments
Table 155. Key Raw Materials Lists
Table 156. Raw Materials Key Suppliers Lists
Table 157. Short Bowel Syndrome Drugs Distributors List
Table 158. Short Bowel Syndrome Drugs Customers List
Table 159. Short Bowel Syndrome Drugs Market Trends
Table 160. Short Bowel Syndrome Drugs Market Drivers
Table 161. Short Bowel Syndrome Drugs Market Challenges
Table 162. Short Bowel Syndrome Drugs Market Restraints
Table 163. Research Programs/Design for This Report
Table 164. Key Data Information from Secondary Sources
Table 165. Key Data Information from Primary Sources
List of Figures
Figure 1. Short Bowel Syndrome Drugs Product Picture
Figure 3. Global Short Bowel Syndrome Drugs Market Share by Type in 2021 & 2028
Figure 3. Oral Short Bowel Syndrome Drugs Product Picture
Figure 4. Tablet Short Bowel Syndrome Drugs Product Picture
Figure 5. Global Short Bowel Syndrome Drugs Market Share by Sale Channel in 2021 & 2028
Figure 6. Hospital Pharmacies
Figure 7. Retail Pharmacies
Figure 8. Online Pharmacies
Figure 9. Short Bowel Syndrome Drugs Report Years Considered
Figure 10. Global Short Bowel Syndrome Drugs Sales 2017-2028 (K Pcs)
Figure 11. Global Short Bowel Syndrome Drugs Revenue, (US$ Million), 2017 VS 2021 VS 2028
Figure 12. Global Short Bowel Syndrome Drugs Revenue 2017-2028 (US$ Million)
Figure 13. Global Short Bowel Syndrome Drugs Revenue Market Share by Region in Percentage: 2021 Versus 2028
Figure 14. Global Short Bowel Syndrome Drugs Sales Market Share by Region (2017-2022)
Figure 15. Global Short Bowel Syndrome Drugs Sales Market Share by Region (2023-2028)
Figure 16. North America Short Bowel Syndrome Drugs Sales YoY (2017-2028) & (K Pcs)
Figure 17. North America Short Bowel Syndrome Drugs Revenue YoY (2017-2028) & (US$ Million)
Figure 18. Europe Short Bowel Syndrome Drugs Sales YoY (2017-2028) & (K Pcs)
Figure 19. Europe Short Bowel Syndrome Drugs Revenue YoY (2017-2028) & (US$ Million)
Figure 20. Asia-Pacific Short Bowel Syndrome Drugs Sales YoY (2017-2028) & (K Pcs)
Figure 21. Asia-Pacific Short Bowel Syndrome Drugs Revenue YoY (2017-2028) & (US$ Million)
Figure 22. Latin America Short Bowel Syndrome Drugs Sales YoY (2017-2028) & (K Pcs)
Figure 23. Latin America Short Bowel Syndrome Drugs Revenue YoY (2017-2028) & (US$ Million)
Figure 24. Middle East & Africa Short Bowel Syndrome Drugs Sales YoY (2017-2028) & (K Pcs)
Figure 25. Middle East & Africa Short Bowel Syndrome Drugs Revenue YoY (2017-2028) & (US$ Million)
Figure 26. The Short Bowel Syndrome Drugs Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2021
Figure 27. The Top 5 and 10 Largest Manufacturers of Short Bowel Syndrome Drugs in the World: Market Share by Short Bowel Syndrome Drugs Revenue in 2021
Figure 28. Global Short Bowel Syndrome Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2017 VS 2021
Figure 29. Global Short Bowel Syndrome Drugs Sales Market Share by Type (2017-2028)
Figure 30. Global Short Bowel Syndrome Drugs Revenue Market Share by Type (2017-2028)
Figure 31. Global Short Bowel Syndrome Drugs Sales Market Share by Sale Channel (2017-2028)
Figure 32. Global Short Bowel Syndrome Drugs Revenue Market Share by Sale Channel (2017-2028)
Figure 33. North America Short Bowel Syndrome Drugs Sales Market Share by Type (2017-2028)
Figure 34. North America Short Bowel Syndrome Drugs Revenue Market Share by Type (2017-2028)
Figure 35. North America Short Bowel Syndrome Drugs Sales Market Share by Sale Channel (2017-2028)
Figure 36. North America Short Bowel Syndrome Drugs Revenue Market Share by Sale Channel (2017-2028)
Figure 37. North America Short Bowel Syndrome Drugs Sales Share by Country (2017-2028)
Figure 38. North America Short Bowel Syndrome Drugs Revenue Share by Country (2017-2028)
Figure 39. U.S. Short Bowel Syndrome Drugs Revenue (2017-2028) & (US$ Million)
Figure 40. Canada Short Bowel Syndrome Drugs Revenue (2017-2028) & (US$ Million)
Figure 41. Europe Short Bowel Syndrome Drugs Sales Market Share by Type (2017-2028)
Figure 42. Europe Short Bowel Syndrome Drugs Revenue Market Share by Type (2017-2028)
Figure 43. Europe Short Bowel Syndrome Drugs Sales Market Share by Sale Channel (2017-2028)
Figure 44. Europe Short Bowel Syndrome Drugs Revenue Market Share by Sale Channel (2017-2028)
Figure 45. Europe Short Bowel Syndrome Drugs Sales Share by Country (2017-2028)
Figure 46. Europe Short Bowel S
  • Global Brain Boosting Supplements Industry Research Report, Growth Trends and Competitive Analysis 2022-2028
    Published: 25-Nov-2022        Price: US 5600 Onwards        Pages: 127
    Report Overview Due to the COVID-19 pandemic and Russia-Ukraine War Influence, the global market for Product Name estimated at US$ million in the year 2022, is projected to reach a revised size of US$ million by 2028, growing at a CAGR of % during the forecast period 2022-2028. The USA market for Brain Boosting Supplements is estimated to increase from $ million in 2022 to reach $ million by 2028, at a CAGR of % during the forecast period of 2023 through 2028. The China mark......
  • Global Sartans API Industry Research Report, Growth Trends and Competitive Analysis 2022-2028
    Published: 25-Nov-2022        Price: US 5600 Onwards        Pages: 127
    Report Overview Due to the COVID-19 pandemic and Russia-Ukraine War Influence, the global market for Product Name estimated at US$ million in the year 2022, is projected to reach a revised size of US$ million by 2028, growing at a CAGR of % during the forecast period 2022-2028. The USA market for Sartans API is estimated to increase from $ million in 2022 to reach $ million by 2028, at a CAGR of % during the forecast period of 2023 through 2028. The China market for Sartans ......
  • Global Vascular Endothelial Growth Factor (VEGF) Antibodies Industry Research Report, Growth Trends and Competitive Analysis 2022-2028
    Published: 25-Nov-2022        Price: US 5600 Onwards        Pages: 111
    Report Overview Due to the COVID-19 pandemic and Russia-Ukraine War Influence, the global market for Product Name estimated at US$ million in the year 2022, is projected to reach a revised size of US$ million by 2028, growing at a CAGR of % during the forecast period 2022-2028. The USA market for Vascular Endothelial Growth Factor (VEGF) Antibodies is estimated to increase from $ million in 2022 to reach $ million by 2028, at a CAGR of % during the forecast period of 2023 through 2......
  • Global Plasma Derived Drugs Industry Research Report, Growth Trends and Competitive Analysis 2022-2028
    Published: 25-Nov-2022        Price: US 5600 Onwards        Pages: 82
    Report Overview Due to the COVID-19 pandemic and Russia-Ukraine War Influence, the global market for Product Name estimated at US$ million in the year 2022, is projected to reach a revised size of US$ million by 2028, growing at a CAGR of % during the forecast period 2022-2028. The USA market for Plasma Derived Drugs is estimated to increase from $ million in 2022 to reach $ million by 2028, at a CAGR of % during the forecast period of 2023 through 2028. The China market for......
  • Global Creatine Kinase Reagent Industry Research Report, Growth Trends and Competitive Analysis 2022-2028
    Published: 25-Nov-2022        Price: US 5600 Onwards        Pages: 107
    Report Overview Due to the COVID-19 pandemic and Russia-Ukraine War Influence, the global market for Product Name estimated at US$ million in the year 2022, is projected to reach a revised size of US$ million by 2028, growing at a CAGR of % during the forecast period 2022-2028. The USA market for Creatine Kinase Reagent is estimated to increase from $ million in 2022 to reach $ million by 2028, at a CAGR of % during the forecast period of 2023 through 2028. The China market ......
  • Global Alanine Aminotransferase Reagent Industry Research Report, Growth Trends and Competitive Analysis 2022-2028
    Published: 25-Nov-2022        Price: US 5600 Onwards        Pages: 105
    Report Overview Due to the COVID-19 pandemic and Russia-Ukraine War Influence, the global market for Product Name estimated at US$ million in the year 2022, is projected to reach a revised size of US$ million by 2028, growing at a CAGR of % during the forecast period 2022-2028. The USA market for Alanine Aminotransferase Reagent is estimated to increase from $ million in 2022 to reach $ million by 2028, at a CAGR of % during the forecast period of 2023 through 2028. The Chin......
  • Global Fructosamine Reagents Industry Research Report, Growth Trends and Competitive Analysis 2022-2028
    Published: 25-Nov-2022        Price: US 5600 Onwards        Pages: 108
    Report Overview Due to the COVID-19 pandemic and Russia-Ukraine War Influence, the global market for Product Name estimated at US$ million in the year 2022, is projected to reach a revised size of US$ million by 2028, growing at a CAGR of % during the forecast period 2022-2028. The USA market for Fructosamine Reagents is estimated to increase from $ million in 2022 to reach $ million by 2028, at a CAGR of % during the forecast period of 2023 through 2028. The China market fo......
  • Global Total Iron-Binding Capacity (TIBC) Reagents Industry Research Report, Growth Trends and Competitive Analysis 2022-2028
    Published: 25-Nov-2022        Price: US 5600 Onwards        Pages: 101
    Report Overview Due to the COVID-19 pandemic and Russia-Ukraine War Influence, the global market for Product Name estimated at US$ million in the year 2022, is projected to reach a revised size of US$ million by 2028, growing at a CAGR of % during the forecast period 2022-2028. The USA market for Total Iron-Binding Capacity (TIBC) Reagents is estimated to increase from $ million in 2022 to reach $ million by 2028, at a CAGR of % during the forecast period of 2023 through 2028.......
  • Global Lipid Injectable Drugs Industry Research Report, Growth Trends and Competitive Analysis 2022-2028
    Published: 25-Nov-2022        Price: US 5600 Onwards        Pages: 102
    Report Overview Due to the COVID-19 pandemic and Russia-Ukraine War Influence, the global market for Product Name estimated at US$ million in the year 2022, is projected to reach a revised size of US$ million by 2028, growing at a CAGR of % during the forecast period 2022-2028. The USA market for Lipid Injectable Drugs is estimated to increase from $ million in 2022 to reach $ million by 2028, at a CAGR of % during the forecast period of 2023 through 2028. The China market f......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs